Surrey researchers Sign in
Back
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
Journal article   Open access  Peer reviewed

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

GR Simpson, A Horvath, NE Annels, T Pencavel, S Metcalf, R Seth, P Peschard, T Price, RS Coffin, H Mostafid, …
BRITISH JOURNAL OF CANCER, Vol.106(3), pp.496-507
31/01/2012
DOI: https://doi.org/10.1038/bjc.2011.577

Abstract

oncolytic HSV bladder cancer micro CT orthotopic model fusogenic glycoprotein prodrug therapy
tif
FIG 6 LARGE12.51 MBDownloadView
ImageSRIDA,  Open Access
pdf
bladder_paper_bjc (2)168.83 kBDownloadView
Text Open Access
pdf
table 1 (1)12.55 kBDownloadView
Text Open Access
url
http://dx.doi.org/10.1038/bjc.2011.577View
Published (Version of record)
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000300302300011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

201 File views/ downloads
38 Record Views
27 Times Cited - Web of Science

Details

Usage Policy

Usage details for all content viewed and downloaded in this site are shared with IRUS-UK (Institutional Repository Usage Statistics UK). Cookies are used to remember your decision. Click Accept to accept usage details sharing and the cookies.

Learn more